Omnipod 5 Automated Insulin Delivery System

The Omnipod 5 is a revolutionary tubeless insulin delivery system developed by Insulet Corporation. Originally founded in the United States in 2000, Insulet sought to improve the lives of people with diabetes by eliminating the cumbersome tubing associated with traditional insulin pumps. The system consists of a wearable, disposable 'Pod' and a controller or compatible smartphone app.

Manufacturing of the Pods is primarily centered in highly automated facilities in Acton, Massachusetts, and potentially other global locations to serve international markets. As a publicly traded company on the NASDAQ, Insulet Corporation remains the ultimate owner of the brand and technology, maintaining its headquarters in the USA. The brand has expanded globally, with local subsidiaries and distribution networks handling its presence in Europe and beyond.